| Bari A, Marcheselli L, Sacchi S, et al.
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 17.
Abstract | Full Citation | Find Related Articles |
| Tassinari D, Drudi F, Lazzari-Agli L, et al.
Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 17.
Full Citation | Find Related Articles |
| Khasraw M, Pavlakis N, McCowatt S, et al.
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Petrausch U, Samaras P, Veit-Haibach P, et al.
Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Paiva CE, Drigo SA, Rosa FE, et al.
Absence of transforming growth factor-{beta} type II receptor is associated with poorer prognosis in HER2-negative breast tumours. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Glimelius B, Spindler KL, Frödin JE, et al.
Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Full Citation | Publisher Full Text | Find Related Articles |
| Xie P, Yue JB, Fu Z, et al.
Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Camerini A, Valsuani C, Mazzoni F, et al.
Phase II trial of single-agent oral vinorelbine in elderly (>=70 years) patients with advanced non-small-cell lung cancer and poor performance status. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Ghesquières H, Ferlay C, Sebban C, et al.
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Mavroudis D, Papakotoulas P, Ardavanis A, et al.
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
